e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Preclinical models for the development of new drugs for respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oral administration of saccharomyces cerevisiae inhibits the allergic airway response in mice
M. Borges, V. Fonseca, T. Milani, A. P. Carvalho, A. Gozzi, R. Prado, V. Bonato, F. Martins, E. Vianna (Ribeirão Preto, Belo Horizonte, Brazil)
Source:
Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Session:
Preclinical models for the development of new drugs for respiratory diseases
Session type:
Thematic Poster Session
Number:
678
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Borges, V. Fonseca, T. Milani, A. P. Carvalho, A. Gozzi, R. Prado, V. Bonato, F. Martins, E. Vianna (Ribeirão Preto, Belo Horizonte, Brazil). Oral administration of saccharomyces cerevisiae inhibits the allergic airway response in mice. Eur Respir J 2013; 42: Suppl. 57, 678
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The effect of trehalose for the allergen-induced airway hyperresponsiveness and airway inflamation in mice
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Characterisation of a steroid-insensitive severe asthma model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Dose-dependent differential effects of thrombin in allergic bronchial asthma
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Effects of LTRA on T cell-induced bronchoconstriction in the mice
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Adjuvant-free mouse model of allergic asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
The immunomodulatory activity of protein S protects against allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Standardization of a murine model of asthma due to soybean inhalation
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Vitamin C inhibits the diisocyanate-induced lung inflammatory response in mice
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Immunohistochemical study on changes of mast cell populations during allergic airway inflammation in mice using HDM model
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
The effect of different PV extracts in the treatment of asthma in an animal model
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016
RIG-I receptors induced by dsRNA challenges in an HDM-mouse model of asthma exacerbation
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
Adoptive transfer of chimeric antigen receptor-T regulatory cells as an effective therapy for allergic asthma
Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology
Year: 2014
Pim1 kinase affects allergic asthma in a HDM-driven mice model
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Immunomodulatory role of IL-37 in asthma pathogenesis
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Absence of proton sensing OGR1 protects against house dust mite-induced allergic airway inflammation
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept